GLP-1 patches: weight loss patches explained

GLP-1 patches are advertised as an easy, non-invasive way to support weight loss. They aim to mimic the effects of the glucagon-like peptide 1 (GLP-1) hormone, a naturally produced hormone which helps regulate your appetite and blood sugar levels.

They are usually sold as transdermal patches. This means they stick to the skin and are supposed to release ingredients that pass through the skin and into the bloodstream.

However, GLP-1 patches are not prescription medicines. They are not regulated in the same way as licensed weight loss treatments and do not come with medical assessment, dose control or ongoing supervision.

While they might seem convenient, there is no strong evidence that they work in the same way or deliver the same results as prescription weight loss treatments, such as Wegovy.

By applying the patch to the skin, manufacturers claim that the medication can be absorbed slowly into the bloodstream, providing appetite-suppressing effects throughout the day.

However, the effectiveness of transdermal absorption is questionable. Medications like GLP-1 are peptides, which work by linking amino acids together, meaning that they are large and typically do not pass through the skin very easily.

This raises questions about whether the body can absorb enough of the medication to have any significant impact on weight loss.

No, GLP-1 patches do not contain licensed GLP-1 receptor agonists such as semaglutide. Instead, they contain ingredients such as vitamins or herbal blends which are not proven to support weight loss.

Semaglutide is the active ingredient used in weight loss treatments like Wegovy and works by closely copying the natural GLP-1 hormone in the body. This is proven to support weight loss.

➤ Some patches may reference “GLP-1 support” or “GLP-1 activation,” but these phrases are marketing terms rather than medical ones. They do not mean the product contains semaglutide or produces the same effects.

There is currently no high-quality, clinical evidence showing that GLP-1 patches lead to weight loss. No extensive, peer-reviewed trials have demonstrated consistent reductions in body weight from using these products.

Claims made online often rely on consumer testimonials or before-and-after images. These do not show cause and effect and are not a substitute for controlled studies. Prescription GLP-1 treatments are supported by large clinical trials, which is how their effectiveness and side effects are understood.

Without evidence from regulated trials, it is not possible to know whether any weight changes seen with patches are due to the product or other factors such as placebo or lifestyle changes.

Are there any medical studies on GLP-1 patches?

There are currently no published clinical trials that show that GLP-1 patches:

• contain licensed GLP-1 receptor agonists such as semaglutide or tirzepatide
• deliver these medicines through the skin in a measurable or reliable way
• lead to clinically meaningful weight loss in people

GLP-1 patches are not approved medicines in the UK. They are typically sold under food supplement or cosmetic regulations, which have very different safety standards.

Licensed GLP-1 medicines must meet strict requirements set by the Medicines and Healthcare products Regulatory Agency (MHRA). This includes proof of effectiveness, safety monitoring, and clear dosing information.

GLP-1 patches do not go through this process, so there is no requirement to prove that they work as advertised.

This difference in regulation is important when deciding which treatments are safe to rely on for long-term weight management.

The differences between GLP-1 patches and prescription injections become clearer when you compare how they are regulated, how they work, and who they are suitable for.

Let’s take a look at the key differences between GLP-1 patches and injections:

This comparison shows why prescription GLP-1 injections offer more reliable and predictable results than patches, despite requiring medical assessment and a higher upfront cost.

Social media platforms play a large role in promoting GLP-1 patches. Influencer content can sometimes focus on quick results, convenience and simplicity. The appeal of GLP-1 patches is that they claim to achieve prescription weight loss results without the high cost.

Additionally, the phrase “needle-free GLP-1” is especially appealing for those who are afraid of needles. But it overlooks how these medicines work in practice. Avoiding injection may sound attractive, but the delivery method can directly affect how effective the treatment is.

➤ Advertising rules for supplements are less strict than for medicines too, which allows for claims that would not be permitted for prescription treatments.

Evidence-based weight loss treatments are available through regulated medical services. Licensed GLP-1 injections are currently the most effective option for people who meet the criteria for treatment.

Through Asda Online Doctor, you can access prescription options following an online assessment and doctor review. These treatments are supported by clinical evidence and medical guidance from real online doctors, which helps balance effectiveness with safety. Speaking to a doctor about your weight loss needs can help them tailor a plan to you.

Lifestyle changes still matter, but medication can be a useful tool when weight loss has been hard to achieve through diet and activity alone.

Wegovy (semaglutide)

Wegovy contains semaglutide, a GLP-1 receptor agonist taken as a once-weekly injection. It is approved by the MHRA, meaning it has met the UK standards for safety, quality and effectiveness.

Clinical trials involving adults with overweight or obesity have shown that semaglutide can lead to substantial weight loss especially when used alongside lifestyle changes.

People taking semaglutide lost significantly more weight than those given a placebo, with benefits maintained over time. These results come from large, longitudinal clinical studies, not social media testimonials or short-term use.

Mounjaro (tirzepatide)

Mounjaro contains tirzepatide, which works on both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is also licensed by the MHRA for weight management, following evidence from multiple large-scale clinical trials.

Tirzepatide has been shown to support greater average weight loss than placebo, with some participants losing a significant amount of their starting weight.

The dual-hormone action helps reduce appetite and food intake more strongly than GLP-1 activity alone. Its approval is based on robust clinical trial data and regulated dosing, which sets it apart from unproven alternatives like patches.

Explore more weight loss treatment options.

GLP-1 patches are often marketed as an easy alternative to injections, but they do not contain licensed GLP-1 medicines and are not proven to support weight loss.

Prescription GLP-1 injections remain the most effective and reliable option for medical weight loss. Choosing regulated treatments through services like Asda Online Doctor provides clearer expectations, better safety and stronger evidence of results.

If you’re struggling with weight loss and are unsure about the best treatment for you, it’s always a good idea to speak to a doctor.

Weight loss can be complex, and a medical professional can help you navigate the options available, ensuring that you’re using a safe and effective method.

Whether you’re considering prescription weight loss medication or need advice on lifestyle changes, Asda Online Doctor can help you make informed decisions about your health.

Explore weight loss treatment options.